Placebo Response Significant in Overactive Bladder
The placebo response is statistically, and possibly clinically, significant in patients with OAB, according to authors of a new systematic review.
General Urology
Gemtesa Approved for Overactive Bladder Treatment
The approval was based on data from the pivotal phase 3 EMPOWUR study.
Prior Radiation Linked to Worse Survival in Bladder Cancer Cases
This study examined bladder cancer that developed after radiation for any cancer potentially affecting the organ, not just prostate cancer.
Tool Could Optimize Antibiotic Prescribing for UTI
A new decision support tool could optimize antibiotic prescribing for uncomplicated urinary tract infections in the outpatient setting.
Race ‘Correction’ in Clinical Algorithms Needs Re-examination
Clinicians should consider whether a race correction will relieve or exacerbate inequities, according to editorialists.
SGLT-2 Inhibitor Use Not Linked to Increased Risk for UTI Events
Findings seen in propensity-matched cohorts vs receipt of DPP-4 inhibitors or GLP-1 agonists.
Fournier Gangrene: A Rare Flesh-Eating Disease
Prompt identification of Fournier gangrene is essential, as the condition can have numerous life-threatening complications such as multi-organ failure and death.
Urinary Incontinence Drug May Reduce Frequency of Hot Flashes
Oxybutynin, an anticholinergic used to treat urinary incontinence, may provide breast cancer survivors with an alternative treatment option for hot flashes, according to new research.
Urinary Incontinence Common in Women Over 50 Years
Nearly half of women older than 50 years report having urinary incontinence.
Diet Less Important Than Genes for High Serum Urate Levels
Diet explains little of the variation in serum urate levels in the general population, while genetic factors make a greater contribution.
- Loading...
Loading...
Next post in Diet and Nutrition Information Center
Loading... 
Loading...